Florida has reported over 461,000 total COVID-19 cases, surpassing New York for the highest per-capita caseload in the United States—but a simple comparison doesn’t represent the critical differences in the data we have for the two outbreaks.
The South continues to be the epicenter of surges in both cases and hospitalizations. In Arizona, Florida, South Carolina, and Texas, COVID-19 deaths have begun to climb following jumps in new cases. And for the first time since April, deaths are rising nationally.
The US has broken its record for new COVID-19 cases three times in the last week. Thirteen states broke their new-case records since Sunday. In the states with the worst outbreaks, hospitalizations and deaths are rising.
Starting in August, new federal rules will require testing labs to report better data on the spread of COVID-19 in the United States. What happens to this new information is up to state and local officials. Journalists, open-data advocates, and members of the public can help us hold governments accountable for collecting and publishing this urgently needed data.
As exposure risk increases, so does the need for more testing. The more we test, the more cases we can identify—which is a good thing. But are we looking at the right metrics to know if we are performing enough tests?
The United States hit a record high for new COVID-19 cases this week. In many areas with rising case counts, testing isn’t keeping up. Meanwhile, hospitalizations in regions with big outbreaks are increasing.
As case counts surge, we look at regional and state-level numbers to find out which recent jumps in COVID-19 case counts are likely to be explained by increased testing, and which are not. For the states with the worst recent numbers, the news is not good.
As cases and hospitalizations continue to drop in the early Northeast epicenters, they are rising—in some areas quite sharply—in the South and West. We look at the numbers and at the relationship between an increase in tests and a rise in case counts.
Probable cases of COVID-19 make up only a small fraction of currently reported cases, but the CDC wants states to do a better job reporting them. So what are they and why do they matter? We took a closer look to help reporters and members of the public better understand this complex COVID-19 metric.
The news this week is mixed and highly regional. In the early US epicenter of the outbreak, cases continue to drop. In the southern and western United States, cases are on the rise, as are COVID-19 hospitalizations. And as always, the lag makes the data difficult to put into context.
For months, we've worked to patch together inconsistent state-reported data into a national set of numbers for COVID-19 case, death, and testing in the US. The CDC has now published a COVID Data Tracker, but their data only partially matches the numbers we get from the state public health authorities. So we took a closer look.
As antibody tests become more widely available across the United States, we call on all states and territories to preserve the integrity and usefulness of their COVID-19 testing data by maintaining separate viral testing and antibody testing counts.